utd_medknow
Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :116
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

POSITION PAPER

Optimizing second-line therapy for chronic myeloid leukemia

Raja T

Year : 2012| Volume: 49| Issue : 1 | Page no: 46-56

   This article has been cited by
 
1 Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib
Yanhong Cheng, Yingchan Hao, Aimei Zhang, Chaojie Hu, Xiaoxiao Jiang, Quan Wu, Xiucai Xu
International Journal of Molecular Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Optimizing patient outcome: Of equal importance in the palliative setting
Parikh, P. and Narayanan, P. and Bhattacharyya, Gs.
Indian Journal of Cancer. 2012; 49(3): 255-259
[Pubmed]  [Google Scholar]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow